The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

A newly approved messenger RNA (mRNA) influenza vaccine could help improve protection against seasonal flu by allowing ...

A new flu vaccine using messenger RNA technology is available at some King Soopers pharmacies in Colorado, offering adults 50 ...

A combination of the personalized cancer vaccine intismeran autogene and Merck's Keytruda just barely cleared analysts’ ...

A New Zealand agency has invested in a US startup developing a vaccine to reduce livestock methane emissions, but the jab does not use mRNA, contrary to conspiratorial posts online reviving Covid-era ...

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...

Until now, the flu shot lineup featured six vaccination options —using live viruses, inactivated viruses or viral antigens—delivered via needle injection or nasal spray. The mRNA vaccine has proven ...

The data marks a fundamental turning point in the prevention of melanoma recurrences, a disease where avoiding relapse and ...

Australian researchers have completed the first head-to-head comparison of three mRNA-lipid nanoparticle vaccine platforms in ...

Denise Fitzsimmons knew that removing the fast-growing lump above her eyebrow in 2024 didn’t eliminate the possibility that her melanoma could return. But a clinical trial at Penn Medicine offered the ...

Explore the potential of a personalized mRNA vaccine that targets specific cancer mutations for advanced melanoma treatment.

Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.